AstraZeneca ( AZN) is trending as the drugmaker's CEO David Brennan announced he will step down on June 1. Brennan has been at the helm of the company for six years. He has received some investor backlash for not doing enough to keep the company competitive as it faces multiple expiring drug patents. AstraZeneca has also struggled of late with setbacks in drug development. The company has increased its deal-making lately in effort to bring in new drugs from other companies. Brennan will be replaced by Chief Financial Officer Simon Lowth, who will take over on an interim basis while AstraZeneca finds a permanent replacement.
Starwood Hotels & Resorts ( HOT) is another popular search. The company reported first-quarter earnings that more than quadrupled on high sales of vacation units.